AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06127589 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Financial Incentive (FI)
Description: A financial incentive (vouchers) of HK$ 500 will be provided for biochemically validated smoking abstinence at 3- and 6-month follow-up. Considering a possibly low engagement rate of the smokers in mHealth-based support (17% in our previous trial, non-engagement mostly due to busy work), additional HK$ 200 will be provided for participants who actively engaged in the mHealth counselling (defined by have discussed quitting process for >2 times) at 3-month follow-up.
Study NCT06127589 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Self-help smoking cessation booklet
Description: A well-designed self-help booklet will be provided to guide and provide detailed information on smoking cessation. The contents include information about the benefits of quitting, smoking and diseases, methods to quit, how to handle withdrawal symptoms, declaration of quitting, etc.
Study NCT06127589 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-help smoking cessation booklet
Description: A well-designed self-help booklet will be provided to guide and provide detailed information on smoking cessation. The contents include information about the benefits of quitting, smoking and diseases, methods to quit, how to handle withdrawal symptoms, declaration of quitting, etc.
Study NCT06127589 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Environmental assessment derived intervention
Description: In a selected subgroup of 50 families with an additional signed consents, four home visits will be done to: 1. Setup an indoor air quality (IAQ) monitor to collect 24hr air quality data (2 weeks), 2. Collect the monitor for data retrieval, 3. Setup the monitor at 6 months follow-up (2 weeks), 4. Collect the monitor for data retrieval.~Environmental assessment derived intervention, including results interpretation and health advice, will be provided via phone calls for the 50 families within 1 week after the data collection.
Study NCT06127589 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Environmental assessment derived intervention
Description: In a selected subgroup of 50 families with an additional signed consents, four home visits will be done to: 1. Setup an indoor air quality (IAQ) monitor to collect 24hr air quality data (2 weeks), 2. Collect the monitor for data retrieval, 3. Setup the monitor at 6 months follow-up (2 weeks), 4. Collect the monitor for data retrieval.~Environmental assessment derived intervention, including results interpretation and health advice, will be provided via phone calls for the 50 families within 1 week after the data collection.
Study NCT05932225 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Propylene glycol solution/drops
Description: commercially available eye drops
Study NCT06149208 — intervention group
Intervention type: BEHAVIORAL
Intervention: Interview
Description: Families will complete interviews about their experiences with the new treatment standard and managing pain at home
Study NCT05484115 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: endovascular aneurysm repair (EVAR) using the Endurant II/IIs stent graft system
Description: treatment of AAA's with wide proximal neck diameters with Endurant II/IIs endograft system
Study NCT05484115 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: endosuture aneurysm repair (ESAR) using Heli-FX EndoAnchor system
Description: treatment of AAA's with wide proximal neck diameters with the Endurant II/IIs in conjunction with the Heli-FX EndoAnchor system
Study NCT06027788 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: CardioGard Embolic Protection Cannula
Description: The CardioGard embolic protection cannula is a device that combines the function of a standard aortic cannula with an added suction mechanism to capture debris that may result from cardiac surgery. The device is comprised of 2 hollow tubes. The first tube is the standard main forward-flow tube to return oxygenated blood to the patient's aorta. The second tube attached to an existing bypass vent port, is a novel element located posteriorly to the main tube; its function is to facilitate blood and particle suction by directing the blood back to the reservoir of the coronary bypass machine, while the retrieved embolic debris is eliminated through the filter of the venous reservoir.
Study NCT06027788 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Standard Aortic Cannula
Description: An aortic cannula is a device that is used routinely during cardiac surgery to return oxygenated blood from the cardiac bypass machine into the patient's aorta.
Study NCT04967196 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Ipilimumab
Description: Given via DoseConnect device or IV
Study NCT04967196 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Given IV
Study NCT04967196 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Lymph Node Assessment
Description: Undergo lymphatic imaging with ICG
Study NCT04967196 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT05182840 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 690517
Description: Film-coated tablets
Study NCT05431478 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Serafilcon A contact lenses
Description: Reusable silicone hydrogel contact lenses worn during the day and removed at night for daily cleaning and disinfection
Study NCT05431478 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Senofilcon A contact lenses
Description: Reusable silicone hydrogel contact lenses worn during the day and removed at night for daily cleaning and disinfection
Study NCT05431478 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: CLEAR CARE
Description: Hydrogen peroxide based contact lens cleaning and disinfecting solution
Study NCT05192993 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: visual motor integration group
Description: Oculomotor exercises as follow:(1) Eye follow with a stationary head 2)Saccadic eye movements 3) Gaze stability 4)Eye/head co-ordination 5)Balancing exercises
Study NCT05192993 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Handwriting intervention programs
Description: (1)Eye motor coordination (2)position in space(3)coping-figure ground(4)spatial relationship(5)visual closure(6)constancy of shapes(7)far and near coping
Study NCT05192993 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: visual motor integration program and Handwriting intervention programs
Description: Oculomotor exercises as follow:(1) Eye follow with a stationary head 2)Saccadic eye movements 3) Gaze stability 4)Eye/head co-ordination 5)Balancing exercises 6)Eye motor coordination (7)position in space(8)coping-figure ground(9)spatial relationship(10)visual closure(11)constancy of shapes(12)far and near coping~Hand writing intervention as follow (1)Eye motor coordination (2)position in space(3)coping-figure ground(4)spatial relationship(5)visual closure(6)constancy of shapes(7)far and near coping
Study NCT01844336 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PBASE system 1.1 + CT100 (active treatment)
Study NCT01844336 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: PBASE system 1.1 + CT100 (placebo treatment)
Study NCT05182840 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo to BI 690517
Description: Film-coated tablets
Study NCT05182840 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Description: Empagliflozin
Study NCT05182840 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Empagliflozin
Description: Empagliflozin
Study NCT05676112 — intervention group
Intervention type: DRUG
Intervention: nintedanib
Description: nintedanib
Study NCT05182840 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo to empagliflozin
Description: Placebo to empagliflozin
Study NCT05182840 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to empagliflozin
Description: Placebo to empagliflozin
Study NCT05676112 — intervention group
Intervention type: DRUG
Intervention: pirfenidone
Description: pirfenidone
Study NCT05297591 — intervention group
Intervention type: OTHER
Intervention: assessment of UL function and prognostic factors
Description: clinical assessments and questionnaires
Study NCT06648603 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Community-based larval source management
Description: This project will foster active engagement with community stakeholders, including healthcare workers, community leaders, and other key informants, through participatory meetings aimed at co-creating and developing larval source reduction measures tailored to community's needs. This method emphasizes a participatory framework, ensuring that interventions are both community-informed and culturally relevant.
Study NCT06648603 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Enhanced Aedes adults trapping (BG-GAT)
Description: Furthermore, the project intends to determine whether the addition of cost-effective, gravid female mosquito-targeting traps, specifically two Biogents Gravid Aedes Traps (BG-GAT) per household, can improve the overall success of these community-based intervention.
Study NCT06648603 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Community-based larval source management with Enhanced Aedes adults trapping (BG-GAT)
Description: The community-based interventions and the BG-GAT deployment will be evaluated in combination to assess their individual and synergistic effects on vector control. This dual strategy combines local participation and practical, evidence-based solutions to address mosquito-borne illness transmission.
Study NCT06109714 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Goal Directed Fluid Therapy
Description: Fluid administration and hemodynamic management guided with the assistance of Edwards Lifesciences ACUMEN monitor
Study NCT04647448 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Application of sensor patch
Description: Application of sensor patch to chest to record acoustic signals due to disturbed blood flow.
Study NCT05058677 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: aerosolized 2% lidocaine (20mg/ml)
Description: The aerosolized solution to be used is 2% lidocaine (20 mg/ml) at a dose of 1.5 mg/kg with a maximum volume of 3 ml or adjusted to a volume of 3 ml with addition of NS solution.The aerosolized solution will be administered with an Aerogen ultrasonic nebulizer, which is standard of care for administering aerosolized solutions in our pediatric intensive care unit (PICU).After each treatment a 3-minute interval will be allowed prior to ETS and there will be a 4-6 hour wash out period between each treatment.
Study NCT05058677 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: instilled 0.9% sodium chloride (NS)
Description: The instilled solution will be given with a standard 3-5 ml syringe.After each treatment a 3-minute interval will be allowed prior to ETS and there will be a 4-6 hour wash out period between each treatment.
Study NCT05058677 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: instilled 2% lidocaine solution
Description: The instilled 2 % lidocaine solution used will be 1.5 mg/kg, with a max volume of 3 ml or adjusted to a volume of 3 ml with addition of NS solution.The instilled solution will be given with a standard 3-5 ml syringe.After each treatment a 3-minute interval will be allowed prior to ETS and there will be a 4-6 hour wash out period between each treatment.
Study NCT04751591 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoscopic resection
Description: Endoscopic submucosal dissection (ESD) or endoscopic full-thickness resection (EFTR) for patients with 2-5cm gastric GISTs
Study NCT04963400 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Analysis of hs-cTnT serum concentration at hospitalization
Description: Analysis of the hs-cTnT serum concentration in the blood drawn at the day of hospitalization
Study NCT04963400 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Analysis of hs-cTnT serum concentration after discharge
Description: Analysis of the hs-cTnT serum concentration in the blood drawn after discharge (60 days after hospitalization)
Study NCT05058677 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endotracheal Suctioning (ETS)
Description: ETS will be performed in a single pass using a closed-system suctioning. Suction will be applied only on withdrawal of the catheter and fraction of inspired oxygen (FIO2) will remain at 100% for 60 seconds following suctioning and then returned to the preprocedural level (baseline).
Study NCT06650449 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mobile App-Based Mental Health Support
Description: This intervention uses a mobile application designed to deliver Cognitive Behavioral Therapy (CBT) techniques. The app provides 12 weekly tasks aimed at reducing emotional distress and depressive symptoms in healthcare workers. Tasks include exercises on emotional regulation, coping strategies, and mindfulness. Participants receive notifications to encourage task completion, and the app tracks progress over the 3-month period. At the start and end of the study, participants will complete the PHQ-9 and GHQ-12 questionnaires to assess their mental health status.
Study NCT04751591 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Laparoscopic partial gastrectomy
Description: Laparoscopic partial gastrectomy for patients with 2-5cm gastric GISTs
Study NCT06652022 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Systematic therapy combined with radiotherapy
Description: Systematic medical therapy is same as the systematic treatment group. SBRT radiotherapy or conventional fractionated radiotherapy can be used according to the extent and size of the metastatic foci. SBRT radiotherapy is preferred, and a higher dose should be given as far as possible when the normal tissues permit, with a preferred single dose of ≥5Gy.
Study NCT06652022 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Systematic drug treatment
Description: The choice of first-line treatment is based on the guidelines, and may include chemotherapy or immune checkpoint inhibitors, or a combination of therapies. For patients who can tolerate cisplatin, chemotherapy is given with the gemcitabine-cisplatin regimen, as follows: gemcitabine 1000mg/m2 d1,8; cisplatin 70 mg/m2, avoiding light, intravenous drip d2; 3 weeks for 1 cycle. For intolerant patients, the gemcitabine-carboplatin regimen is given as follows: gemcitabine 1000 mg/m2 d1,8, IV, carboplatin (4.5×\[GFR+25\]) mg, IV, d1; 3 weeks as 1 cycle. Immune checkpoint inhibitors and targeted agents may be administered if the patient does not tolerate chemotherapy; either in combination with chemotherapy or directly as first line.
Study NCT05603000 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Emotion Focused Family Therapy
Description: The Emotion Focused Family Therapy (EFFT) intervention for this study will be delivered to groups of four to ten parents over six weekly sessions of two hours each. The goal of EFFT is to teach and empower parents to coach their child to process the emotions at the source of their mental health symptoms, to increase their child's adaptive behaviours, and to repair emotional injuries within the parent-child relationship. EFFT also targets parents' own emotional challenges that may prevent them from feeling capable or being able to support their child's treatment.~Each EFFT session will include introductions, psychoeducation about emotion and psychopathology, introduction of skills, experiential activities (e.g., chair work), open discussion and feedback, and homework activities covering the foci of EFFT: emotion coaching, behaviour coaching, therapeutic apology, and parental emotion blocks.
Study NCT05385783 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CYB003
Description: CYB003 is a synthetic psilocybin analog.
Study NCT05385783 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: CYB003
Description: CYB003 is a synthetic psilocybin analog.
Study NCT06279377 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stabilization Exercises
Description: * Stabilizer Pressure Biofeedback device will be used in deep neck flexors training. Once the starting level is determined, training will be carried out with 2 mmHg pressure increases until the target value is 30 mmHg.~* During the exercises performed with the elastic resistance band, the patient will be asked to move the band with his hands (neck extension, right-left lateral flexion).~* During the exercises with the elastic ball, you will be asked to press your head on the ball at 90 degree angles (in 4 positions).~* Exercises will be performed in 10 repetitions by maintaining muscle contraction for 10 seconds. Exercises will be performed as 1 set of 10 repetitions or 2 sets of 10 repetitions, depending on the patient's tolerance. When 2 sets are completed successfully, the color of the elastic resistance band or the level of the exercise will be changed and continued.
Study NCT06279377 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Exercises
Description: * Cervical flexion, extension, lateral flexion and rotation movements will be performed within the scope of the warm-up and cool-down program. Cervical movements will be limited to approximately 30 degrees in the early period.~* As posture exercises, you will be asked to do scapular retraction and turning your shoulders forward and backward. In addition to these movements, pectoral stretching, anterior and posterior capsule stretching exercises will be performed.~* Elastic resistance bands will be used during neck exercises. Patients will be asked to perform cervical flexion, extension and right-left lateral flexion movements against the fixed band.~* Patients will be asked to continue each exercise for 10 seconds. Exercises will be performed as 1 set of 10 repetitions or 2 sets of 10 repetitions, depending on the patient's tolerance. When 2 sets are completed successfully, the elastic resistance band color will be changed and the exercise will progress.
Study NCT05171673 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Licart™ (diclofenac epolamine) topical system
Description: The Licart™ (diclofenac epolamine) topical system was designed to deliver the nonsteroidal anti-inflammatory drug (NSAID) diclofenac to the site of a minor soft tissue injury through topical application. This investigational product (IP) is a 10 cm x 14 cm topical system comprised of an adhesive material containing 1.3% diclofenac epolamine that is bound to a non-woven polyester felt backing and covered with a polypropylene film release liner. The release liner is removed prior to topical application to the skin.
Study NCT05385783 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychotherapy
Description: Manualized psychotherapy (called EMBARK) performed by facilitators
Study NCT05385783 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Psychotherapy
Description: Manualized psychotherapy (called EMBARK) performed by facilitators
Study NCT06260800 — intervention group
Intervention type: OTHER
Intervention: Validation CEQ
Description: In initial assessment, EQ-5D-5L and HADS questionnaires were completed. After sessions 1 and 2, CEQ and WAI-S were filled. Finally, EQ-5D-5L was completed before the fourth session.
Study NCT05385783 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT05385783 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychological Support
Description: Manualized psychological support performed by facilitators
Study NCT05385783 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Psychological Support
Description: Manualized psychological support performed by facilitators
Study NCT06706141 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PowerPoint presentation.
Description: The training included topics such as breast anatomy; breast cancer incidence in Somalia, mortality, morbidity rates; breast cancer risk factors, importance of screening methods; The messages on breast self-examination, health belief models, breast cancer awareness, confidence for BSE, and perceived barriers/benefits for BSE were presented in a PowerPoint presentation. The procedure for performing breast self-examination was described using the English edition of Bristol-Myers Squibb Oncology. In the movie, BSE was made simpler with schematics showing the breast area that needed to be covered. Simple directions on which fingers to use and how to move them over the breast were provided. After the film, the emphasis shifted to helping students gain more self-assurance in their ability to accurately complete each BSE step. Students were encouraged to use proper palpation technique to find lumps by performing a breast examination on a silicone breast model.
Study NCT06725979 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: maxillary expansion using hyrax expander
Description: The rapid expansion of the upper jaw will be performed using palatal expander with hyrax screw, which will be activated 2x a day, until the needed width is reached (according to the cast analysis).
Study NCT06725173 — intervention group
Intervention type: GENETIC
Intervention: Targeted Long-read sequencing
Description: All patient's will undergo targeted long-read sequencing to resolve genomic and epigenomic signatures of the RB1 gene
Study NCT06725693 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: 18F/68Ga-Exendin 4
Description: Each subject receive a single intravenous injection of 68Ga/18F-Exendin 4, and undergo PET/CT imaging within the specificed time.
Study NCT06727409 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Finerenone
Description: Finerenone 10mg or 20 mg as tolerated on top of maximal tolerated RASi and stable SGLT2i therapy